Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC)

Clinical trial NCT07050472 · COMPLETED

Trial details

NCT number: NCT07050472
Sponsor: Anhui Shi, MD
Status: COMPLETED
Study type: OBSERVATIONAL

Small-cell Lung Cancer

Start date: 2025-08-11
Primary completion: 2025-08-12
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.